April 6, 2021

Interview with… Dr. Jim Lalonde, Head of Microbial Business Area at INSCRIPTA

April 6, 2021

Inscripta joins EuropaBio: delivering global biotechnology advances

March 31, 2021

EuropaBio response to the EGE report ‘Ethics of Genome Editing’

March 29, 2021

Abolis joins the EuropaBio 25th Anniversary in 2021

March 25, 2021

EuropaBio Statement – Vaccine production scale up: International collaboration remains the key

March 22, 2021

EuropaBio and P-BIO launch the National Associations Council Summit 2021 – Building on Biotechnology: from vaccines to Economic Growth for Europe

March 15, 2021

Abolis joins EuropaBio: Sustainable Bio-Based Products

March 9, 2021

Catalent joins the EuropaBio 25th Anniversary in 2021

March 5, 2021

Webinar Report: Measuring the Economic Footprint of the Biotechnology Industry in Europe

March 1, 2021

Rare Disease Week 2021 – Interview with Dr. Ravi Rao, Head of Research & Development, Chief Medical Officer at Sobi

March 1, 2021

EuropaBio Celebrates 25 Years of Biotech Innovation with 2021 Anniversary Programme

February 24, 2021

European Health Emergency Preparedness and Response Authority (HERA) Consultation – EuropaBio’s Feedback

February 15, 2021

The Business of Biotechnology: Growing for Europe’s tomorrow

February 12, 2021

EuropaBio and Alexion: RARE Conversations (Take Two) Keeping Rare Disease Patients In The Centre Of Discussion

February 12, 2021

EuropaBio Response to Public Consultation on the Evaluation of Patient Rights in Cross-Border Healthcare

February 4, 2021

EuropaBio draft response to the IIA on European Health Data Space

February 2, 2021

Measuring the economic footprint of the Biotechnology Industry in Europe (WifOR Study)

January 29, 2021

Building a European Health Union

January 28, 2021

European Biotech Associations Letter to the European Commission regarding the ongoing evaluation of the Orphan Medicinal Products Regulation

January 20, 2021

Revision of the EU legislation on medicines for children and rare diseases

December 24, 2020

Joint Statement: Comitology Reform Threatens Innovation

December 20, 2020

EuropaBio Comments on the Draft Delegated Act on Climate-Related Objectives under the Taxonomy Regulation

November 30, 2020

Call for more effective EU regulation of Clinical Trials with Advanced Therapy Medicinal Products consisting of or containing Genetically Modified Organisms

November 25, 2020

An EU IP Action Plan for strong industrial ecosystems

 

BIOTECH NEWSLETTER


Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe

FOLLOW US HERE


Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


facebook
twitter
instagram
linkedin
youtube
 

BIOTECH NEWSLETTER


Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
April 15, 2021

An EU Vision for Life Science and Biotechnology for a Healthy and Sustainable EU

With the ambitious target to cut greenhouse gas emissions by 55% compared to 1990 levels by 2030 and the EU Green Deal, the EU has set […]
February 1, 2020

What if we used biology instead of chemistry for manufacturing?

Converting plant biomass into high-value chemicals with the help of improved microorganisms.
January 20, 2020

What if we used algae to make biofuel?

Adjusting a specific algae gene with genome editing, enabling the algae to be a feedstock for biofuels.
January 5, 2020

What if we could transform wood into food preservatives?

Converting plant biomass into high-value chemicals with the help of improved microorganisms.
Become a member